Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
NCT04588129
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
LB-102
Sponsor
LB Pharmaceuticals Inc.
Collaborators
[object Object]